Table 2 |
||||
|
CMV serostatus of patients with autoimmune disease |
||||
|
CMV-positive |
||||
|
|
||||
|
Patient's |
||||
|
diagnosis |
Autoantibody |
% |
No./no. tested |
P |
|
|
||||
|
SLE |
Sm+ |
63 |
12/19 |
|
|
Sm– |
57 |
12/21 |
ns |
|
|
RNP+ |
74 |
17/23 |
||
|
RNP– |
41 |
7/17 |
0.05 |
|
|
MCTD |
Sm+ |
50 |
1/2 |
|
|
Sm– |
35 |
6/17 |
ns |
|
|
RNP+ |
37 |
7/19 |
||
|
DM/PM |
NA* |
60 |
9/15 |
|
|
|
||||
|
*Not available. DM, dermatomyositis, ns, not significant, PM, polymyositis. |
||||
|
Newkirk et al. Arthritis Res 2001 3:253 doi:10.1186/ar310 |
||||